Stephen Williams

Stephen Williams, Ph.D., has been a Partner with Catalyst Advisors since 2012. Steve led discovery biology and pre-clinical development for radiopharmaceuticals at DuPont / New England Nuclear, resulting in the discovery and development of Cardiolite® and Neurolite®. He also led strategic product planning at DuPont Merck Pharmaceuticals. He was a Medical Director in new product planning for CNS diseases at Bristol-Myers Squibb. As the head of business development, he executed a successful IPO at Progenitor, a biotechnology company. Steve received his B.S. in Biology from the University of North Carolina at Chapel Hill and his Ph.D. in Pharmacology from Duke University.